Switzerland

  • 16 Aug 2002
A group of around five private equity sponsors circling the vitamins and fine chemicals division of pharmaceutical company Roche have gone through to the second round of bidding. In an announcement released by Roche on Wednesday, the company said that the divestment timetable was on schedule. The ...

Please take a trial or subscribe to access this content.

Contact our subscriptions team to discuss your access: subs@globalcapital.com

Corporate access

To discuss GlobalCapital access for your entire department or company please contact our subscriptions sales team at: subs@globalcapital.com or find out more online here.

GlobalCapital European securitization league table

Rank Lead Manager/Arranger Total Volume $m No. of Deals Share % by Volume
1 BNP Paribas 12,508 23 18.18
2 Bank of America Merrill Lynch (BAML) 8,059 25 11.72
3 Lloyds Bank 5,761 18 8.38
4 Citi 5,606 15 8.15
5 JP Morgan 5,007 7 7.28

Bookrunners of Global Structured Finance

Rank Lead Manager Amount $m No of issues Share %
  • Last updated
  • Today
1 Citi 92,032.58 259 11.01%
2 Bank of America Merrill Lynch 79,057.17 220 9.45%
3 JPMorgan 69,156.83 197 8.27%
4 Wells Fargo Securities 68,746.03 193 8.22%
5 Credit Suisse 55,529.51 142 6.64%